Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Repeat Kidney Biopsies from the AURORA 2 Study of Voclosporin in Active Lupus Nephritis (KIDNEY WEEK 2023) - Oct 15, 2023 - Abstract #TH-OR29; Pres time: Nov 2, 2023; 05:42 PM - 05:51 PM; Location: Room 103, Pennsylvania Convention Center; "As expected, mean activity scores improved in both treatment arms. Importantly, exposure to voclosporin was not associated with chronic injury, with the mean index remaining stable at follow-up. Similar to the overall population, patients treated with voclosporin saw greater reductions in UPCR over 3 years of treatment; safety outcomes from this small subgroup were also consistent with outcomes in AURORA 1." 
Biopsy • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease
https://www.asn-online.org/education/kidneyweek/2023/program-abstract.aspx?controlId=3939853
 
Samir V. Parikh1; Clint Abner2; Ernie Yap2; Krista Piper2; Robert B. Huizinga3; Henry Leher2
 
Oct 15, 2023
 
Prev Next